Sign in
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
Journal article   Peer reviewed

Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults

Dick Menzies, Menonli Adjobimey, Rovina Ruslami, Anete Trajman, Oumou Sow, Heejin Kim, Joseph Obeng Baah, Guy B Marks, Richard Long, Vernon Hoeppner, …
The New England journal of medicine, Vol.379(5), pp.440-453
02/08/2018
PMID: 30067931

Abstract

Nearly one quarter of the global population has been infected with Mycobacterium tuberculosis , and there are more than 10 million new infections per year. In an open-label trial, 9 months of isoniazid was compared with 4 months of rifampin as therapy for latent tuberculosis infection.

Details